INBX Competitors & Alternatives
Compare Inhibrx Biosciences, Inc. with similar stocks in the same industry
Biotechnology
INBX
Main Stock$97.93
Tradestie Score
57
Market Cap
$492.21M
Revenue Growth
-1.0%
Analyst Upside
+172.3%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VCEL
Vericel Corporation
|
$39.44
|
$1.56B | 83.6 | 65 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$88.32
|
$1.55B | - | 67 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$39.57
|
$1.55B | 12.7 | 57 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$31.01
|
$1.55B | - | 47 | Compare |
|
NVAX
Novavax Inc
|
$10.60
|
$1.54B | - | 33 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$15.95
|
$1.50B | 7.1 | 44 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$28.98
|
$1.50B | - | 40 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$28.08
|
$1.49B | - | 51 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$25.23
|
$1.43B | - | 73 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$16.96
|
$1.42B | - | 71 | Compare |
More INBX Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry